Paul Streck - 19 Jan 2023 Form 4/A - Amendment Insider Report for ALBIREO PHARMA, INC.

Role
Chief Medical Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
27 Jan 2023, 16:23:23 UTC
Date Of Original Report
25 Jan 2023
Previous filing
21 Dec 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Award $0 +55,000 +86% $0.000000 118,966 19 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, 6.25% of the shares every three months thereafter beginning on April 19, 2024 and ending on January 19, 2025, and 12.5% of the shares every three months thereafter beginning on April 19, 2025 and ending on January 19, 2026.
F2 Represents 118,966 restricted stock units.

Remarks:

This Form 4/A is being filed solely to correct the vesting schedule of the RSUs granted on January 19, 2023.